CollPlant Biotechnologies (CLGN) FCF Margin Growth (1y) (2019 - 2025)
CollPlant Biotechnologies (CLGN) FCF Margin Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -279,045.00 |
| Sep 30, 2025 | 7.90 Mn |
| Jun 30, 2025 | 13,493.00 |
| Dec 31, 2024 | -136,853.00 |
| Sep 30, 2024 | -8.27 Mn |
| Jun 30, 2024 | -146,293.00 |
| Mar 31, 2024 | -247,243.00 |
| Dec 31, 2023 | 2.07 Mn |
| Sep 30, 2023 | 263,855.00 |
| Jun 30, 2023 | 538,018.00 |
| Dec 31, 2022 | -2.11 Mn |
| Sep 30, 2022 | -105,853.00 |
| Jun 30, 2022 | -495,951.00 |
| Dec 31, 2021 | -25,453.00 |
| Sep 30, 2021 | -3.96 Mn |
| Jun 30, 2021 | -26,008.00 |
| Mar 31, 2021 | 48,803.00 |
| Dec 31, 2020 | 23,112.00 |
| Sep 30, 2020 | 3.82 Mn |
| Jun 30, 2020 | 3,978.00 |